Incidence of Sinusoidal Obstruction Syndrome Following Mylotarg (Gemtuzumab Ozogamicin, GO): a Prospective Observational Study in Routine Clinical Practice.
Autor: | Tallman, Marti n S, McDonald, George B *, DeLeve, Laurie D *, Obi-Tabot, Eliot *, Kollmer, Carl *, Feingold, Jay M |
---|---|
Zdroj: | In Blood 16 November 2008 112(11):956-956 |
Databáze: | ScienceDirect |
Externí odkaz: |